Health In Tech Seeks Approval to Triple Authorized Shares and Expand Yorkville SEPA
HIT is trading near its 52-week low of $0.775 (1.7% below the low) on elevated volume (39× avg).
Summary
Health In Tech's preliminary proxy seeks approval to triple authorized shares to 720 million, issue shares beyond the Yorkville SEPA's 19.99% cap, and double its equity plan reserve — while disclosing Nasdaq board independence non-compliance.
Key Events · Corporate Governance and Compliance · HIT
-
Authorized Shares Triple to 720M
Proposal Two would increase authorized Class A shares from 150M to 650M, raising total authorized capital from 220M to 720M shares — a 500M share increase.
-
SEPA Exchange Cap Removal Sought
Proposal Three asks stockholders to approve issuing shares beyond the 13,100,378-share Exchange Cap (19.99% of outstanding) to Yorkville under the $20M SEPA, enabling full utilization of the facility.
-
Equity Plan Reserve Doubles
Proposal Four would increase the 2024 Equity Incentive Plan reserve from 10,677,849 to 20,677,849 Class A shares — a 10M share increase for future grants.
-
Nasdaq Independence Non-Compliance
The company has only two independent directors and two Audit Committee members after Sanjay Shrestha's August 10, 2026 resignation, violating Nasdaq Listing Rules 5605(b)(1) and 5605(c)(2)(A). Cure period expires February 6, 2027.
Analysis · HIT · Finance
Health In Tech is asking stockholders to approve a massive expansion of its authorized share count — from 220 million to 720 million shares — alongside approval to issue shares beyond the 19.99% Exchange Cap under its Yorkville SEPA. The company also wants to double its equity incentive plan reserve by 10 million shares. With the stock trading near its 52-week low at $0.76 and a market cap of roughly $54 million, these proposals would give management enormous flexibility to issue shares at deeply depressed prices. The proxy also reveals the company is out of compliance with Nasdaq's independent director and audit committee requirements following a board resignation in August, adding a governance red flag to the dilution story.
How filings like this one have moved
In the 30 days to Oct 18, 2026, 37.4% of the 928 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.78%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HIT was trading at $0.76 on NASDAQ in the Finance sector, with a market capitalization of approximately $53.7M. The 52-week trading range was $0.77 to $4.02. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.